A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability andEfficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects with Alopecia Areata,Alopecia Universalis or Alopecia Totalis

Project: Research project

Description

A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects with Alopecia Areata, Alopecia Universalis or Alopecia Totalis
StatusActive
Effective start/end date6/15/186/30/22

Funding

  • ACLARIS THERAPEUTICS, INC

Fingerprint

Alopecia Areata
Alopecia
Multicenter Studies
Suspensions
Placebos
Safety
Alopecia universalis